Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
1134
-
Total shares
-
71.6M
-
Shares change
-
-1.15M
-
Total reported value, excl. options
-
$38.6B
-
Value change
-
-$654M
-
Put/Call ratio
-
2.34
-
Number of buys
-
476
-
Number of sells
-
-492
-
Price
-
$539.93
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q1 2024
2 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q1 2024.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 1,134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.6M shares
of 80.8M outstanding shares and own 88.61% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.21M shares), VANGUARD GROUP INC (8.48M shares), STATE STREET CORP (3.78M shares), ALLIANCEBERNSTEIN L.P. (2.99M shares), Fundsmith LLP (2.71M shares), GEODE CAPITAL MANAGEMENT, LLC (2.16M shares), BAMCO INC /NY/ (2.1M shares), FRANKLIN RESOURCES INC (1.55M shares), Invesco Ltd. (1.47M shares), and MORGAN STANLEY (1.23M shares).
This table shows the top 1134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.